Clinical Trial Update: Comparing the Extent to Which AQ280 is Made Available in the Body After Single Oral Doses of a Capsule Formulation Versus a Tablet for Oral Suspension Formulation [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study comparing single-dose AQ280 capsule versus tablet for oral suspension, evaluating systemic exposure in eosinophilic esophagitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• AQ280

Snippet

Sponsor: AQILION AB | Conditions: Eosinophilic Esophagitis | Phase 1 | Status: COMPLETED